Redbud Labs

Redbud Labs is a biotechnology startup based in the United States, founded in 2010. The company specializes in developing advanced microfluidic technologies with a focus on streamlining lab workflow complexity. Their flagship product, NAxtract, is a cartridge-based automated sample preparation platform that aims to revolutionize the sample prep market by making automation accessible. The platform's key feature is its ability to process 8 samples in 30 minutes, offering a disruptive solution with no setup, service contracts, and minimal overhead. Redbud Labs' technology is underpinned by a patented microfluidic agitation technology, Redbud Post, enabling sample prep up to 1000x faster than traditional on-cartridge methods. The company's intellectual property portfolio includes 18 granted patents, 36 pending patents, and trade secrets. The company's headquarters is located in Research Triangle Park, North Carolina, comprising a custom-built lab space dedicated to production, prototyping, and general lab applications. Redbud Labs is certified ISO 9001 and 45001 for its quality, health, and safety management systems. The company's most recent investment was a grant received on February 2, 2021, with the details of the investors undisclosed. Redbud Labs' technology has wide-ranging applications across various industries, including biotechnology, healthcare, and manufacturing, making NAxtract a promising and versatile solution in markets such as liquid biopsy, infectious disease diagnostics, and genomic surveillance.